Trial intelligence / Profile preview

Tea Tree Oil vs Azithromycin in MGD-associated Dry Eye Disease

NCT06921525Phase 2Completed

Start
Mar 2025
Primary completion
Oct 2025
Modality
Hydrogel Systems, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tea tree oil gel in dry eye disease (DED), meibomian gland dysfunction (MGD). Started Mar 2025; status: completed.

02

Drugs

tea tree oil gel
03

Conditions

dry eye disease (DED)meibomian gland dysfunction (MGD)

Beyond the preview

Go deeper on NCT06921525.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06921525.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call